Synthetic DNA immunotherapy in biochemically relapsed prostate cancer

Journal article

Peer reviewed

N. Shore, E.I. Heath, L.T. Nordquist, H. Cheng, K. Bhatt, M. Morrow, T. McMullan, K. Kraynyak, J. Lee, B. Sacchetta, …

Annals of oncology, Vol.29, pp.viii290-viii290

10/2018

PMID: 32136666

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy284.039View

Published (Version of record) Open

1 Record Views

Title: Synthetic DNA immunotherapy in biochemically relapsed prostate cancer
Creators: N. Shore - Carolina Urologic Research Center
E.I. Heath - The Barbara Ann Karmanos Cancer Institute
L.T. Nordquist - Urology Cancer Center and GU Research Network
H. Cheng - University of Washington Medical Center
K. Bhatt - Inovio Pharmaceuticals (United States)
M. Morrow - Inovio Pharmaceuticals (United States)
T. McMullan - Inovio Pharmaceuticals (United States)
K. Kraynyak - Inovio Pharmaceuticals (United States)
J. Lee - Inovio Pharmaceuticals (United States)
B. Sacchetta - Inovio Pharmaceuticals (United States)
et al.
Publication Details: Annals of oncology, Vol.29, pp.viii290-viii290
Publisher: Elsevier Ltd
Identifiers: 991006262539002656
Academic Unit: Radiology
Language: English
Resource Type: Journal article